Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized placebo-controlled trial of Cerebrolysin after endovascular thrombectomy for acute ischemic stroke
MOH_2022-02-01_010580Phase 4Not yet recruiting
- Sponsor
- ד"ר רוני אייכל
- Start
- Jan 2022
- Modality
- Peptide-based Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Native Peptides → Peptides, Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in ischemic stroke comparing CEREBROLYSIN after EVT with Placebo after EVT (2 arms). Planned start Jan 2022; status: not yet recruiting.
02
Drugs
cerebrolysin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on MOH_2022-02-01_010580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-02-01_010580.